Shikiko Watanabe
Shikiko Watanabe publishes mostly in Psychiatry and Mental health, Oncology and Pediatrics, Perinatology and Child Health, on topics such as Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #3,445,725 of 7,710,434 ranked researchers
- Rank in Belgium
- #31,094 of 67,186
- Works
- 18
- Citations
- 685
- Citations per work
- 38.1
What does Shikiko Watanabe research?
Shikiko Watanabe's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1055.8%
- Medicine1055.8%
- Everything else526.9%
- Life Sciences317.3%
- 1Psychiatry and Mental health19% of their works
- 2Oncology14% of their works
- 3Pediatrics, Perinatology and Child Health14% of their works
- 4Molecular Biology12% of their works
- 5Radiology, Nuclear Medicine and Imaging10% of their works
- 6Immunology6% of their works
Research topics
- Epilepsy research and treatment
- Pharmacological Effects and Toxicity Studies
- Monoclonal and Polyclonal Antibodies Research
- Drug Transport and Resistance Mechanisms
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Neuroscience and Neuropharmacology Research
- Cancer-related Molecular Pathways
Which keywords describe Shikiko Watanabe's research?
The keywords of their largest research topics: Antiepileptic Drugs, Epilepsy, Seizures, Prenatal Exposure, Teratogenicity, Fc Receptors, Therapeutic Antibodies and ATP-dependent Transporters.
- p53
- Synaptic Plasticity
- PROTACs
- Cell Cycle
- Multidrug Resistance
- ATP-dependent Transporters
- Fc Receptors
- Prenatal Exposure
- Epilepsy
- Antiepileptic Drugs
- Seizures
- Teratogenicity
- Therapeutic Antibodies
- Cancer Therapy
- BET Bromodomains
- Neurotransmission
- Proteasome
- Ubiquitin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antiepileptic Drugs162 topics
- Epilepsy91 topic
- Seizures91 topic
- Prenatal Exposure71 topic
- Teratogenicity71 topic
- Fc Receptors51 topic
- Therapeutic Antibodies51 topic
- ATP-dependent Transporters41 topic
- Cancer Therapy42 topics
- Multidrug Resistance41 topic
- BET Bromodomains21 topic
- Cell Cycle21 topic
- Neurotransmission21 topic
- PROTACs21 topic
- Proteasome21 topic
- Synaptic Plasticity21 topic
- Ubiquitin21 topic
- p5321 topic
Where does Shikiko Watanabe work?
Shikiko Watanabe's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Shikiko Watanabe have?
OpenAlex counts 18 works and 685 citations for Shikiko Watanabe, an h-index of 12, ranking #3,445,725 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shikiko Watanabe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.